FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+6.82%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$18.4B
AUM Growth
-$1.28B
(-6.5%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-6.72%
Top 10 Holdings %
Top 10 Hldgs %
26.32%
Holding
585
New
66
Increased
220
Reduced
190
Closed
68
Top Buys
| 1 |
NVIDIA
NVDA
|
$123M |
| 2 |
Snowflake
SNOW
|
$119M |
| 3 |
COUP
Coupa Software Incorporated
COUP
|
$99.8M |
| 4 |
Marvell Technology
MRVL
|
$84.9M |
| 5 |
Schlumberger
SLB
|
$72M |
Top Sells
| 1 |
MGM Resorts International
MGM
|
$166M |
| 2 |
Alibaba
BABA
|
$128M |
| 3 |
Apple
AAPL
|
$124M |
| 4 |
Amazon
AMZN
|
$114M |
| 5 |
Microsoft
MSFT
|
$105M |
Sector Composition
| 1 | Technology | 29.81% |
| 2 | Healthcare | 25.72% |
| 3 | Industrials | 11.09% |
| 4 | Consumer Discretionary | 11.02% |
| 5 | Communication Services | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
GSK
GSK
$81.6B
| $1.06M | 0.01% |
30,062
+3,270
| +12% | +$115K |
|
377
Dow Inc
DOW
$17.4B
| $1.01M | 0.01% |
20,130
+545
| +3% | +$27.5K |
|
|
BBBY
378
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.01M | 0.01% |
402,510
+31
| +0% | +$78 |
|
379
Equinix
EQIX
$75.7B
| $994K | 0.01% |
1,517
| – | – |
|
380
Sarepta Therapeutics
SRPT
$1.96B
| $975K | 0.01% |
+7,522
| New | +$975K |
|
381
Newmont
NEM
$83.7B
| $942K | 0.01% |
19,960
+5,449
| +38% | +$257K |
|
382
Ventyx Biosciences
VTYX
$180M
| $928K | 0.01% |
28,290
+16,411
| +138% | +$538K |
|
383
Arhaus
ARHS
$1.62B
| $920K | 0.01% |
94,341
| – | – |
|
384
New Oriental
EDU
$7.98B
| $836K | ﹤0.01% |
+24,000
| New | +$836K |
|
|
XYZ
385
Block, Inc.
XYZ
$45.7B
| $737K | ﹤0.01% |
11,730
+10,171
| +652% | +$639K |
|
386
American Express
AXP
$227B
| $680K | ﹤0.01% |
4,600
-136,060
| -97% | -$20.1M |
|
387
The RealReal
REAL
$999M
| $666K | ﹤0.01% |
532,981
+274
| +0.1% | +$343 |
|
388
Sprinklr
CXM
$2.02B
| $662K | ﹤0.01% |
81,002
-498,593
| -86% | -$4.07M |
|
389
Zoetis
ZTS
$67.9B
| $657K | ﹤0.01% |
4,484
| – | – |
|
|
VMW
390
DELISTED
VMware, Inc
VMW
| $643K | ﹤0.01% |
5,234
-1,126
| -18% | -$138K |
|
391
Accenture
ACN
$159B
| $642K | ﹤0.01% |
2,407
-75
| -3% | -$20K |
|
392
W.W. Grainger
GWW
$47.5B
| $622K | ﹤0.01% |
1,119
-80
| -7% | -$44.5K |
|
393
Xylem
XYL
$34.2B
| $618K | ﹤0.01% |
5,586
+198
| +4% | +$21.9K |
|
394
RXO
RXO
$2.71B
| $603K | ﹤0.01% |
+35,042
| New | +$603K |
|
395
Autodesk
ADSK
$69.5B
| $595K | ﹤0.01% |
3,184
| – | – |
|
396
Synopsys
SNPS
$111B
| $588K | ﹤0.01% |
1,843
+1,489
| +421% | +$475K |
|
397
Rhythm Pharmaceuticals
RYTM
$6.78B
| $582K | ﹤0.01% |
19,988
-298
| -1% | -$8.68K |
|
398
Arcellx
ACLX
$4.03B
| $571K | ﹤0.01% |
+18,433
| New | +$571K |
|
399
Aptiv
APTV
$17.5B
| $529K | ﹤0.01% |
5,682
-126,745
| -96% | -$11.8M |
|
400
MaxCyte
MXCT
$150M
| $501K | ﹤0.01% |
91,759
| – | – |
|